Bristol-Myers Squibb Co (BMY) stock saw a decline, ending the day at $56.57 which represents a decrease of $-0.22 or -0.39% from the prior close of $56.79. The stock opened at $56.34 and touched a low ...

EXEL's shares surge 50% in a year on the back of the strong performance of its lead drug Cabometyx. We are optimistic about ...

DGRO's annual reconstitution continues to drive consistent dividend growth and high-quality portfolio adjustments. See why I ...

Investors often hold blue-chip stocks at the core of their portfolios. That makes sense. After all, blue-chip companies are ...